drugset / Trial / NCT00962663

Effects of ICA-105665 Using the Intradermal Capsaicin and Ultraviolet B (UV-B) Models in Healthy Male Subjects

NCT00962663

Phase 1 Completed 25 enrolled Pfizer
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this study is; to determine the pharmacodynamic (PD) effects of ICA-105665 using the intradermal (ID) capsaicin model in healthy male subjects, and to investigate the effect of ICA-105665 on inflammatory hyperalgesia using the ultraviolet B (UV-B) model in healthy male subjects.

Timeline

Start
2009-08
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ICA-105665 Unknown 200 mg
Comparator Ibuprofen Small molecule 800 mg

Indications

No indication recorded.